Fonds Cancer

Vorst ·KBO/BCE: BE 0421.375.522

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	26-06-2025	35 d early	2025-00180691
31-12-2023	31-07-2024	10-07-2024	21 d early	2024-00229921
31-12-2022	31-07-2023	11-07-2023	20 d early	2023-00238344
31-12-2021	31-07-2022	27-07-2022	4 d early	2022-20250111
31-12-2020	31-07-2021	20-07-2021	11 d early	2021-37500137
31-12-2019	31-07-2020	27-07-2020	4 d early	2020-34800115
31-12-2018	31-07-2019	25-07-2019	6 d early	2019-39200216
31-12-2017	31-07-2018	09-08-2018	9 d late	2018-44600507
31-12-2016	31-07-2017	21-08-2017	21 d late	2017-45500226
31-12-2015	31-07-2016	26-08-2016	26 d late	2016-48600430

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€5.20M
Current assets	29/58	€5.20M
Stocks & contracts in progress	3	€432k
Amounts receivable within one year	40/41	€24k
Investments	50/53	€3.55M
Cash & bank	54/58	€1.19M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€5.20M
Equity	10/15	€5.19M
Contributions / capital	10/11	€3.78M
Reserves	13	€1.41M
Accumulated profits (losses)	14	€0
Amounts payable	17/49	€14k
Amounts payable within one year	42/48	€3k
Trade debts payable within one year	44	€3k
Income statement
Gross operating margin	9900	€600k
Operating result	9901	€-685k
Financial income	75	€122k
Financial charges	65	€1k
Result before taxes	9903	€-565k
Income taxes	67/77	€21k
Net result for the period	9904	€-586k
Result to be appropriated	9905	€-586k

Summary

Legal nameFR	Fonds Cancer
AbbreviationFR	F.O.C.A.